Detalhe da pesquisa
1.
Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours.
Br J Cancer
; 120(3): 294-300, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30636773
2.
Expression of somatostatin receptors 2 and 5 in circulating tumour cells from patients with neuroendocrine tumours.
Br J Cancer
; 115(12): 1540-1547, 2016 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27875519
3.
Enumeration and Molecular Characterisation of Circulating Tumour Cells in Endometrial Cancer.
Oncology
; 91(1): 48-54, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27256106
4.
Protocol for the EACH trial: a multicentre phase II study evaluating the safety and antitumour activity of the combination of avelumab, an anti-PD-L1 agent, and cetuximab, as any line treatment for patients with recurrent/metastatic head and neck squamous cell cancer (HNSCC) in the UK.
BMJ Open
; 13(11): e070391, 2023 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38011968
5.
Prognostic Threshold for Circulating Tumor Cells in Patients With Pancreatic and Midgut Neuroendocrine Tumors.
J Clin Endocrinol Metab
; 106(3): 872-882, 2021 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33180939
6.
Whole-genome sequencing of single circulating tumor cells from neuroendocrine neoplasms.
Endocr Relat Cancer
; 28(9): 631-644, 2021 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34280125